AU3132495A - Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids - Google Patents

Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids

Info

Publication number
AU3132495A
AU3132495A AU31324/95A AU3132495A AU3132495A AU 3132495 A AU3132495 A AU 3132495A AU 31324/95 A AU31324/95 A AU 31324/95A AU 3132495 A AU3132495 A AU 3132495A AU 3132495 A AU3132495 A AU 3132495A
Authority
AU
Australia
Prior art keywords
antacids
treatment
pharmaceutical compositions
receptor antagonists
gastrointestinal distress
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31324/95A
Inventor
Jeanette Louise Brandley
Michael Alan Brandley
Dolores Dimaria
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU3132495A publication Critical patent/AU3132495A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU31324/95A 1994-07-20 1995-07-18 Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids Abandoned AU3132495A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27763294A 1994-07-20 1994-07-20
US277632 1994-07-20
PCT/US1995/009004 WO1996002262A2 (en) 1994-07-20 1995-07-18 Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids

Publications (1)

Publication Number Publication Date
AU3132495A true AU3132495A (en) 1996-02-16

Family

ID=23061722

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31324/95A Abandoned AU3132495A (en) 1994-07-20 1995-07-18 Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids

Country Status (4)

Country Link
AU (1) AU3132495A (en)
CO (1) CO4410201A1 (en)
PE (1) PE33896A1 (en)
WO (1) WO1996002262A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019259791B2 (en) 2018-04-27 2024-03-28 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
JPH06505498A (en) * 1991-04-04 1994-06-23 ザ、プロクター、エンド、ギャンブル、カンパニー Chewable antacid composition
ATE128351T1 (en) * 1991-04-04 1995-10-15 Procter & Gamble EDIBLE PHARMACEUTICAL COMPOSITIONS FOR TREATING DIGESTIVE TRACT PAIN.
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
WO1996002262A2 (en) 1996-02-01
WO1996002262A3 (en) 1997-02-13
CO4410201A1 (en) 1997-01-09
PE33896A1 (en) 1996-09-02

Similar Documents

Publication Publication Date Title
AU6076198A (en) Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers
IL122345A0 (en) Benzamide derivatives their use as vasopressin antagonists processes for the preparation thereof and pharmaceutical compositions containing the same
IL99246A0 (en) Angiotensin ii receptor antagonists and pharmaceutical compositions containing them
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
NZ299693A (en) 1,4-dioxino derivatives of indole and quinoline; pharmaceutical compositions
HUP9801692A3 (en) Benzimidazole compounds, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
ZA989150B (en) Mouth hygienic composition for the treatment of halitosis
HUP0001442A3 (en) Sulfonamide derivatives and pharmaceutical compositions containing them for the treatment of endothelin-mediated disorders
IL116998A0 (en) Novel indoline compounds processes for their preparation and their use for the treatment of CNS disorders
HUP0100737A3 (en) Use of phytosterol for preventing and delaying the onset of alzheimer's disease and phytosterol containing pharmaceutical compositions
IL114492A0 (en) Benzimidazole derivatives their preparation and pharmaceutical compositions containing them
AU3642795A (en) Endothelin receptor antagonists for the treatment of emesis
IL118325A0 (en) Integrin receptor antagonists and pharmaceutical compositions containing them
HUP0003851A3 (en) Pharmaceutical composition for the treatment or prevention of glomerulopathy
HUP0600501A3 (en) Use of cs-866 for producing pharmaceutical composition for the treatment of arteriosclerosis
GB2343117B (en) Benzimidazole pharmaceutical composition and process of preparation
IL141081A0 (en) Use of biogenic estrogen sulfamates for the production of pharmaceutical compositions and pharmaceutical compositions containing biogenic estrogen sulfamates
IL113123A (en) Mono-or bicyclic compounds their preparation and pharmaceutical compositions containing them
HUP9904073A3 (en) Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid
IL117623A (en) Maltitol composition and its preparation
HUP9802634A3 (en) Use of benzimidazoles for the manufacture of pharmaceutical compositions for the treatment of leukemia
HUP0004648A3 (en) 3-substituted tetrahydropyridopyrimidinone derivatives and their use for producing pharmaceutical compositions
AU7468096A (en) Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils
HUP0002929A3 (en) 2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions